文献速递药物不良反应与药物警戒

东盟及部分非东盟国家药物警戒活动与定量信号检测算法使用调查

A Survey on Pharmacovigilance Activities in ASEAN and Selected Non-ASEAN Countries, and the Use of Quantitative Signal Detection Algorithms.
PubMed 文献 · Drug Saf · 2017-01-01

该研究于2015年11月至2016年6月向9个东盟国家和7个非东盟国家的药物警戒中心发放问卷,评估药物警戒现状、上市后安全监测来源、信号检测方法及定量信号检测算法需求。

要点

  • 东盟国家年均ADR报告数3至50000份,非东盟国家7000至1103200份。

核心结论

  • 医务人员自发ADR报告仍是安全监测最常用来源。
  • 东盟国家信号检测以传统逐例审查为主,随着报告增长,开发定量信号检测算法将有助于检测安全信号。

研究设计与样本

  • 2015年11月至2016年6月向9个东盟国家和7个非东盟国家的药物警戒中心发放问卷,收集药物警戒状态及定量信号检测算法使用信息。

主要发现

  • 所有参与国家均开展药物警戒活动,但处于不同发展阶段。
  • 东盟国家年均ADR报告数范围为3至50000份,非东盟国家为7000至1103200份。
  • 主要限制为缺乏知识和/或缺乏资源。

关键数值与推荐

  • 东盟国家年均ADR报告数3至50000份。
  • 非东盟国家年均ADR报告数7000至1103200份。

临床怎么用

  • 资源有限地区可优先巩固自发报告逐例审查,并逐步引入定量信号检测算法。
  • 针对知识和资源不足,可开展信号检测方法培训并配置工具。

局限性

  • 问卷仅覆盖9个东盟国家和7个非东盟国家,代表性有限。
  • 数据收集时间为2015年11月至2016年6月,可能不反映当前状况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Most Countries have pharmacovigilance (PV) systems in place to monitor the safe use of health products. The process involves the detection and assessment of safety issues from various sources of information, communicating the risk to stakeholders and taking other relevant risk minimization measures. OBJECTIVES: This study aimed to assess the PV status in Association of Southeast Asian Nation (ASEAN) countries, sources for postmarket safety monitoring, methods used for signal detection and the need for a quantitative signal detection algorithm (QSDA). Comparisons were conducted with centres outside ASEAN. METHODS: A questionnaire was sent to all PV centres in ASEAN countries, as well as seven other countries, from November 2015 to June 2016. The questionnaire was designed to collect information on the status of PV, with a focus on the use of a QSDA. RESULTS: Data were collected from nine ASEAN countries and seven other countries. PV activities were conducted in all these countries, which were at different stages of development. In terms of adverse drug reaction (ADR) reports, the average number received per year ranged from 3 to 50,000 reports for ASEAN countries and from 7000 to 1,103,200 for non-ASEAN countries. Thirty-three percent of ASEAN countries utilized statistical methods to help detect signals from ADR reports compared with 100% in the other non-ASEAN countries. Eighty percent agreed that the development of a QSDA would help in drug signal detection. The main limitation identified was the lack of knowledge and/or lack of resources. CONCLUSION: Spontaneous ADR reports from healthcare professionals remains the most frequently used source for safety monitoring. The traditional method of case-by-case review of ADR reports prevailed for signal detection in ASEAN countries. As the reports continue to grow, the development of a QSDA would be useful in helping detect safety signals.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Chan CL, Ang PS, Li SC, et al. A Survey on Pharmacovigilance Activities in ASEAN and Selected Non-ASEAN Countries, and the Use of Quantitative Signal Detection Algorithms. Drug Saf. 2017. PMID: 28247278. doi:10.1007/s40264-017-0510-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。